Literature DB >> 8595930

Effects of interferon-gamma on cell differentiation and cytokine production of a human monoblast cell line, U937.

T Ishizuka1, I Hirata, M Adachi, F Kurimoto, T Hisada, K Dobashi, M Mori.   

Abstract

The U937 cell, a human monoblast cell line, has been used as a model to study the function of human monocytes. We investigated the effects of interferon-gamma (IFN-gamma) on superoxide anion (O2-) production, cell surface antigens, and cytokine production of U937 cells. IFN-gamma treatment enhanced O2- production of fMLP or PMA-stimulated U937 cells. IFN-gamma increased the ratio of CD23 and CD11b positive cells. The fluorescence intensity of CD14 and CD25 was enhanced by IFN-gamma treatment. U937 cells produced IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha by lipopolysaccharide (LPS) stimulation. IFN-gamma treatment enhanced TNF-alpha production, but decreased IL-6 production. These results suggest that IFN-gamma differentiates U937 cells to monocyte-like cells and it regulates the production systems of IL-6 and TNF-alpha separately in U937 cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8595930     DOI: 10.1007/bf01534567

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  27 in total

1.  Interferon gamma drastically modifies the regulation of interleukin 1 genes by endotoxin in U937 cells.

Authors:  C Ucla; P Roux-Lombard; S Fey; J M Dayer; B Mach
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

2.  Regulation of Fc epsilon R2/CD23 gene expression by cytokines and specific ligands (IgE and anti-Fc epsilon R2 monoclonal antibody). Variable regulation depending on the cell types.

Authors:  T Kawabe; M Takami; M Hosoda; Y Maeda; S Sato; M Mayumi; H Mikawa; K Arai; J Yodoi
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

3.  Establishment and characterization of a human histiocytic lymphoma cell line (U-937).

Authors:  C Sundström; K Nilsson
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

4.  IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.

Authors:  D Aderka; J M Le; J Vilcek
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

5.  Interferon-gamma induces phosphorylation of multiple small-molecular-weight proteins in U937 cells.

Authors:  T M Schepers; J B Klein; P W Feldhoff; W L Dean; K R McLeish
Journal:  J Interferon Res       Date:  1992-08

6.  Regulation of TNF-alpha, IL-1 and IL-6 synthesis in differentiating human monoblastoid leukemic U937 cells.

Authors:  R Hass; G Lonnemann; D Männel; N Topley; A Hartmann; L Köhler; K Resch; M Goppelt-Strübe
Journal:  Leuk Res       Date:  1991       Impact factor: 3.156

7.  Synergism of interleukin 6 and 1 alpha,25-dihydroxyvitamin D3 in induction of myeloid differentiation of human leukemic cell lines.

Authors:  A J Duits; W Dimjati; J G van de Winkel; P J Capel
Journal:  J Leukoc Biol       Date:  1992-03       Impact factor: 4.962

8.  Proteases and oxidants in experimental pulmonary inflammatory injury.

Authors:  I U Schraufstätter; S D Revak; C G Cochrane
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

9.  Interleukin-1 and tumour necrosis factor production by human monocytoid cells: study on a single cell level.

Authors:  A Simbirtsev; E Prokopieva; E Ivanova; V Konusova; N D Perumov; S Ketlinsky
Journal:  Eur Cytokine Netw       Date:  1992 Jul-Aug       Impact factor: 2.737

10.  Cytokine appearance in human endotoxemia and primate bacteremia.

Authors:  D G Hesse; K J Tracey; Y Fong; K R Manogue; M A Palladino; A Cerami; G T Shires; S F Lowry
Journal:  Surg Gynecol Obstet       Date:  1988-02
View more
  1 in total

1.  Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators.

Authors:  J An; R C Ribeiro; P Webb; J A Gustafsson; P J Kushner; J D Baxter; D C Leitman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.